The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Activation and activities of the p53 tumour suppressor protein
Open accessAbstract
The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Guerra, B., Götz, C., Wagner, P., Montenarh, M., & Issinger, O. (1997) · Oncogene · doi:10.1038/sj.onc.1201112 · Cited by 63
Potential roles for p53 in nucleotide excision repair
McKay, B. C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1389 · Cited by 63
Hay, T., & Meek, D. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01850-0 · Cited by 62
Arriola, E. L., Lopez, A. R., & Chresta, C. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202391 · Cited by 58
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
McCormick, F. P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0336 · Cited by 57
Adenovirus‐mediated Transfer of p53‐related Genes Induces Apoptosis of Human Cancer Cells
Ishida, S., Yamashita, T., Nakaya, U., & Tokino, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00929.x · Cited by 57
Wani, M. A., Zhu, Q., El-Mahdy, M. A., & Wani, A. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.765 · Cited by 56
Lohrum, M. A. E., & Scheidtmann, K. H. (1996) · PubMed · Cited by 55
The Werner syndrome protein contributes to induction of p53 by DNA damage
Blander, G., Zalle, N., Martínez-Leal, J. F., Bar‐Or, R. L., Yu, C., & Oren, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0171fje · Cited by 49
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.
Yam, C. H., Siu, W. Y., Arooz, T., Chiu, C. H. S., Lau, A. W. S., Wang, X. Q., & Poon, R. Y. C. (1999) · PubMed · Cited by 46
Maya, R., & Oren, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203658 · Cited by 41
Identification of a CK2 phosphorylation site in mdm2.
Götz, C., Kartarius, S., Scholtes, P., Nastainczyk, W., & Montenarh, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00882.x · Cited by 39
Zeng, X., Keller, D., Wu, L., & Lu, H. (2000) · PubMed · Cited by 26
p53-Independent Down-Regulation of Mdm2 in Human Cancer Cells Treated with Adriamycin
Ma, Y., Yuan, R., Meng, Q., Goldberg, I. D., Rosen, E. M., & Fan, S. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0201 · Cited by 16
(1995) · PubMed
Cited by
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Self-citationUnderstanding protein non-folding
Uversky, V. N., & Dunker, A. K. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.017 · Cited by 1,186
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Drug discovery in the ubiquitin–proteasome system
Nalepa, G., Rolfe, M., & Harper, J. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2056 · Cited by 608
Xie, H., Vucetic, S., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Uversky, V. N., & Obradovic, Z. (2007) · Journal of Proteome Research · doi:10.1021/pr060392u · Cited by 560
Metadata
- Authors
- Bálint, É., & Vousden, K. H.
- Venue
- British Journal of Cancer
- Published
- 2001-12
- Volume
- 85
- Issue
- 12
- Pages
- 1813-1823
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1990431346
- Cited by
- 313
- References
- 215
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.